The Myelodysplastic Syndromes Channel on VJHemOnc is an independent medical education platform, supported with funding from Geron (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MDS 2020 | MDS pathology and comorbidities
Theo de Witte
• 5 Mar 2020
Theo de Witte, MD, Radboud University Medical Center, Nijmegen, The Netherlands, discusses the pathology of myelodysplastic syndromes (MDS) and how our understanding has expanded since the molecular era. The issue of comorbidities in MDS patients is also outlined. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.
